Becton Dickinson Price to Sales Ratio 2012-2026 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of September 16, 2026 is .
| Becton Dickinson P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-09-16 | 181.85 | 2.30 | |
| 2026-06-30 | 150.44 | $79.16 | 1.90 |
| 2026-03-31 | 155.21 | $77.50 | 2.00 |
| 2025-12-31 | 149.66 | $76.28 | 1.96 |
| 2025-09-30 | 143.56 | $75.70 | 1.90 |
| 2025-06-30 | 131.40 | $68.50 | 1.92 |
| 2025-03-31 | 173.69 | $69.24 | 2.51 |
| 2024-12-31 | 171.25 | $71.05 | 2.41 |
| 2024-09-30 | 181.13 | $69.40 | 2.61 |
| 2024-06-30 | 174.86 | $68.36 | 2.56 |
| 2024-03-31 | 184.41 | $68.11 | 2.71 |
| 2023-12-31 | 180.98 | $67.61 | 2.68 |
| 2023-09-30 | 191.11 | $67.53 | 2.83 |
| 2023-06-30 | 194.49 | $66.46 | 2.93 |
| 2023-03-31 | 181.70 | $65.67 | 2.77 |
| 2022-12-31 | 185.94 | $65.33 | 2.85 |
| 2022-09-30 | 162.33 | $65.71 | 2.47 |
| 2022-06-30 | 178.99 | $63.87 | 2.80 |
| 2022-03-31 | 187.78 | $63.50 | 2.96 |
| 2021-12-31 | 176.95 | $63.68 | 2.78 |
| 2021-09-30 | 172.36 | $65.36 | 2.64 |
| 2021-06-30 | 169.96 | $63.88 | 2.66 |
| 2021-03-31 | 169.35 | $61.62 | 2.75 |
| 2020-12-31 | 173.68 | $60.36 | 2.88 |
| 2020-09-30 | 160.95 | $57.60 | 2.79 |
| 2020-06-30 | 164.95 | $61.04 | 2.70 |
| 2020-03-31 | 157.88 | $63.37 | 2.49 |
| 2019-12-31 | 186.26 | $63.45 | 2.94 |
| 2019-09-30 | 172.72 | $63.25 | 2.73 |
| 2019-06-30 | 171.56 | $63.21 | 2.71 |
| 2019-03-31 | 169.46 | $62.97 | 2.69 |
| 2018-12-31 | 152.42 | $63.22 | 2.41 |
| 2018-09-30 | 175.99 | $61.44 | 2.86 |
| 2018-06-30 | 161.07 | $58.96 | 2.73 |
| 2018-03-31 | 145.23 | $57.09 | 2.54 |
| 2017-12-31 | 142.97 | $54.93 | 2.60 |
| 2017-09-30 | 130.42 | $54.96 | 2.37 |
| 2017-06-30 | 129.39 | $55.65 | 2.33 |
| 2017-03-31 | 121.19 | $56.62 | 2.14 |
| 2016-12-31 | 108.93 | $57.15 | 1.91 |
| 2016-09-30 | 117.74 | $57.54 | 2.05 |
| 2016-06-30 | 110.68 | $57.43 | 1.93 |
| 2016-03-31 | 98.70 | $57.23 | 1.72 |
| 2015-12-31 | 99.73 | $53.33 | 1.87 |
| 2015-09-30 | 85.49 | $49.93 | 1.71 |
| 2015-06-30 | 90.89 | $46.32 | 1.96 |
| 2015-03-31 | 91.74 | $42.76 | 2.15 |
| 2014-12-31 | 88.55 | $42.99 | 2.06 |
| 2014-09-30 | 72.11 | $42.75 | 1.69 |
| 2014-06-30 | 74.60 | $42.16 | 1.77 |
| 2014-03-31 | 73.49 | $41.54 | 1.77 |
| 2013-12-31 | 69.03 | $41.14 | 1.68 |
| 2013-09-30 | 62.17 | $40.49 | 1.54 |
| 2013-06-30 | 61.12 | $39.35 | 1.55 |
| 2013-03-31 | 58.84 | $38.66 | 1.52 |
| 2012-12-31 | 47.85 | $37.76 | 1.27 |
| 2012-09-30 | 47.77 | $36.66 | 1.30 |
| 2012-06-30 | 45.18 | $35.51 | 1.27 |
| 2012-03-31 | 46.65 | $34.60 | 1.35 |
| 2011-12-31 | 44.62 | $33.93 | 1.32 |
| 2011-09-30 | 43.52 | $33.42 | 1.30 |
| 2011-06-30 | 50.88 | $31.93 | 1.59 |
| 2011-03-31 | 46.78 | $30.88 | 1.51 |
| 2010-12-31 | 49.40 | $29.83 | 1.66 |
| 2010-09-30 | 43.10 | $29.61 | 1.46 |
| 2010-06-30 | 39.12 | $29.83 | 1.31 |
| 2010-03-31 | 45.31 | $29.55 | 1.53 |
| 2009-12-31 | 45.17 | $29.10 | 1.55 |
| 2009-09-30 | 39.76 | $28.33 | 1.40 |
| 2009-06-30 | 40.45 | $27.66 | 1.46 |
| 2009-03-31 | 37.96 | $27.60 | 1.38 |
| 2008-12-31 | 38.41 | $27.49 | 1.40 |
| 2008-09-30 | 44.84 | $27.31 | 1.64 |
| 2008-06-30 | 45.27 | $27.18 | 1.67 |
| 2008-03-31 | 47.64 | $26.25 | 1.81 |
| 2007-12-31 | 46.23 | $25.52 | 1.81 |
| 2007-09-30 | 45.23 | $24.67 | 1.83 |
| 2007-06-30 | 40.93 | $24.20 | 1.69 |
| 2007-03-31 | 42.11 | $23.49 | 1.79 |
| 2006-12-31 | 38.29 | $22.82 | 1.68 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $51.228B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |